The Clorox Company (NYSE:CLX – Free Report) – Equities research analysts at Zacks Research decreased their Q2 2025 earnings estimates for Clorox in a research note issued on Wednesday, August 14th. Zacks Research analyst R. Lohia now forecasts that the company will post earnings per share of $1.56 for the quarter, down from their previous estimate of $1.61. The consensus estimate for Clorox’s current full-year earnings is $6.40 per share. Zacks Research also issued estimates for Clorox’s Q3 2025 earnings at $1.73 EPS, Q4 2025 earnings at $1.91 EPS, Q3 2026 earnings at $1.81 EPS and Q4 2026 earnings at $1.84 EPS.
Several other research analysts also recently commented on the stock. Barclays lifted their price target on shares of Clorox from $122.00 to $130.00 and gave the stock an “underweight” rating in a research note on Monday, August 5th. UBS Group cut their target price on shares of Clorox from $164.00 to $159.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Evercore ISI cut their target price on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a report on Wednesday, May 1st. JPMorgan Chase & Co. cut their target price on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating on the stock in a report on Friday, August 2nd. Finally, Deutsche Bank Aktiengesellschaft raised their target price on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Six investment analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $141.94.
Clorox Trading Up 1.5 %
CLX stock opened at $151.42 on Monday. The company has a market capitalization of $18.80 billion, a PE ratio of 78.46, a price-to-earnings-growth ratio of 1.97 and a beta of 0.39. Clorox has a one year low of $114.68 and a one year high of $158.89. The company’s 50 day moving average price is $137.20 and its two-hundred day moving average price is $142.36. The company has a debt-to-equity ratio of 9.73, a quick ratio of 0.53 and a current ratio of 0.90.
Hedge Funds Weigh In On Clorox
Several large investors have recently modified their holdings of the stock. Wallace Capital Management Inc. raised its position in shares of Clorox by 1.4% in the 2nd quarter. Wallace Capital Management Inc. now owns 13,354 shares of the company’s stock worth $1,822,000 after purchasing an additional 180 shares during the last quarter. Regal Investment Advisors LLC raised its position in Clorox by 19.8% in the 2nd quarter. Regal Investment Advisors LLC now owns 24,779 shares of the company’s stock worth $3,382,000 after buying an additional 4,101 shares during the last quarter. Quarry LP raised its position in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after buying an additional 114 shares during the last quarter. NewEdge Advisors LLC raised its position in Clorox by 3.5% in the 2nd quarter. NewEdge Advisors LLC now owns 16,747 shares of the company’s stock worth $2,285,000 after buying an additional 564 shares during the last quarter. Finally, Bontempo Ohly Capital Mgmt LLC raised its position in Clorox by 0.6% in the 2nd quarter. Bontempo Ohly Capital Mgmt LLC now owns 28,382 shares of the company’s stock worth $3,873,000 after buying an additional 163 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Clorox Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, August 30th. Stockholders of record on Wednesday, August 14th will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.22%. The ex-dividend date is Tuesday, August 13th. This is a positive change from Clorox’s previous quarterly dividend of $1.20. Clorox’s payout ratio is currently 252.85%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Lowe’s Stock: Hold Now, Buy it When it Dips
- What Are Dividends? Buy the Best Dividend Stocks
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.